2022 Speakers

Abhishek Srivastava

VP, Cell Therapy Development

Athenex

Alba Gonzalez

Director of Research

Senti Biosciences

Aman Singh

Associate Director Clinical Pharmacology M&S, Cell Therapy

Takeda

Anahid Jewett

Professor & Director Tumor Immunology Laboratory

UCLA

Anders Holm

Chief Operating Officer

Zelluna Immunotherapy

Andre Kunert

Principal Scientist

Sanofi

Arndt Schottelius

Chief Scientific Officer

Affimed

Austin Bigley

VP Research & Development

Indapta Therapeutics

Ayman Kabakibi

Chief Operating Officer

Wugen

Beau Webber

Assistant Professor

University of Minnesota

Björn Önfelt

Professor

Karolinsk Institutet

Bradley Glover

EVP & Chief Technology Officer

Celularity

Branden Moriarity

Principal Investigator

University of Minnesota

Brian Garrison

Director

Senti Biosciences

Caimei Zhang

Senior Research Investigator

University of Pennsylvania

Christian Capitini

Associate Professor, Pediatrics

University of Wisconsin-Madison

Christina Coughlin

CEO

Cytoimmune

Christopher Nowers

CEO

ONK Therapeutics

Dan Kemp

CEO

Wugen

Debora Barton

Chief Medical Officer

Carisma Therapeutics

Don Healey

Chief Technology Officer

Adicet Bio

Eliot Bourk

CBO

Chimeric Therapeutics

Emily Levy

Senior Scientist

Merck

Emily Mace

Assistant Professor of Pediatric Immunology

Columbia University

Evren Alici

Head of Cell & Gene Therapy Group

Karolinska Institutet

Ezequiel Zylberberg

VP Product Development and Planning

Akron Biotech

Gregory Fiore

CEO

Exacis Biosciences

Hans-Gustaf Ljunggren

Professor

Karolinska Institutet

Heather Stefanski

Vice President, Medical Services

The National Marrow Donor Program®/Be The Match®

James Trager

Chief Scientific Officer

NKarta

Jeffrey Miller

Professor of Medicine

University of Minnesota

Jennifer Dashnau

Head of Analytical Development & Quality Control

Century Therapeutics

Jode Goodridge

Associate Director

Fate Therapeutics

Johan Liwing

CEO

XNK Therapeutics

Joseph Gold

VP Technical Operations

Catamaran Bio

Kai Pinkernell

Chief Medical Officer

glycostem

Kanya Rajangam

Chief Medical Officer

NKarta Therapeutics

Kate Rochlin

VP Operations & Innovations

IN8bio

Kevin Flynn

R&D Manager

Bio-Techne

Kimberly Schluns

Senior Director Research

Kite: A Gilead Company

Marcel Zwaal

CEO

Gadeta

Marcia Blackmoore

CMC Project Leader, Genomic Medicines Unit

Sanofi

Mark Lowdell

Chief Scientific Officer

INmune Bio

Mark Moore

CEO

Gempharmatech US

Mary Reilly

Chief Operating Officer

ONK Therapeutics

Melissa Berrien-Elliott

Instructor

Washington University School of Medicine, St. Louis

Melody Eble

Vice President Global Regulatory Affairs

Century Therapeutics

Michael DeRidder

SVP Corporate Strategy and New Product Planning

Catamaran Bio

Michael O’Dwyer

Founder & CSO

ONK Therapeutics

Neil Sheppard

Adjunct Associate Professor

University of Pennsylvania

Nicholas Boyd

CDO

Cartherics

Nicholas Huntington

Professor Biochemistry & Molecular Biology

Monash University

Nina Möker

R&D Reagents Manager Allogeneic Cell Therapy

Miltenyi Biotec

Peter Flynn

Co-Founder & COO

Artiva Bio

Philip Lee

Chief Technology Officer

Senti Biosciences

Ralph Brandenberger

SVP Tech Ops

NKarta Therapeutics

Rizwan Romee

Associate Professor of Medicine

Dana-Farber Cancer Institute

Robert Igarashi

Vice President Discovery & Preclinical Development

Sanofi

Sandro Matosevic

Assistant Professor

Purdue University

Serhat Gumrukcu

Executive Director & Director of Research

Seraph Research Institute

Stacey Cranert

Director, Immuno-Oncology

Poseida Therapeutics

Stanley Frankel

Chief Medical Officer

Cytovia Therapeutics

Tanima Abedin

Senior Field Application Specialist

ScaleReady

Todd Fehniger

Professor of Medicine

Washington University School of Medicine, St. Louis

Uriel Moreno

Scientist

Johnson & Johnson

Volker Huppert

CDO

glycostem

Will Singleterry

Commercial Director - Immuno-Oncology

LUMICKS

William Sandborn

Co-Founder & CMO

Shoreline Biosciences